Recruiting NCT07175519
Safety and Efficacy of Aneurysms Treated With Endovascular Devices
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Endovascular treatment of aneurysms.
- Who it may be relevant to
- Registry conditions: Brain Aneurysm, Stroke, Intracranial Hemorrhages. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United Kingdom
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
In this project the investigators study the safety and efficacy of the recent endovascular devices used in treatment of brain aneurysms.
Interventions
- Device Endovascular treatment of aneurysms
Aneurysm can be treated by endovascular devices using catheters, Treatment modalities can include coils, stents, flow diverters as well as intrasaccular devices
Primary outcome measures
- Evaluate predictive factors of aneurysm recurrence after endovascular device embolization (efficacy). [Time frame: Done at short-term (30 days) post procedural and long term (up to 5 years) post procedural]
Eligibility criteria
Inclusion criteria
- All patients undergoing endovascular aneurysm treatment.
Exclusion criteria
- All endovascular patients NOT undergoing aneurysm treatment e.g. stents used for stroke treatment; devices and materials used for dAVF, AVM treatments.
- Insufficient background data available e.g., to determine size of aneurysm and device.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United Kingdom · 1 center
- Kings College Hospital, London — London
Publications
- Booth TC, Bassiouny A, Lynch J, Sonwalkar H, Bleakley A, Iqbal A, Minett T, Buwanabala J, Narata AP, Patankar T, Islim FI, Kandasamy N, Balasundaram P, Sciacca S, Siddiqui J, Walsh D, Tolias C, Kailaya-Vasan A, Sultan AA, Abd El-Latif M, Mortimer A, Sastry A. Outcome study of the Pipeline Vantage Embolization Device (second version) in unruptured (and ruptured) aneurysms (PEDVU(R) study). J Neuroi PMID 38071557
Identifiers
NCT: NCT07175519 · 287395